Fig. 1From: Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesotheliomaFlow diagram of establishment and characterization of MPMOs. Including the generation of MPMOs and primary cell from patients, as well as the histological characterization, genomic analysis, drug screen, and xenografts models of MPMOs.Back to article page